Atlanta, Georgia - IBM and the American Cancer Society today announced a partnership to create the first advisor for people fighting cancer, powered by Watson cognitive computing. The initiative, announced at the 13th Annual World Health Care Congress, aims to provide cancer patients, survivors, and caregivers with trusted ACS resources and guidance personalized to an individual's unique journey against cancer.

New Orleans, Louisiana - Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet-B (UVB) light delayed melanoma onset in a mouse model of the disease, according to research presented here at the AACR Annual Meeting 2016, April 16-20. These data suggest that the mouse model can be used to identify new, more effective melanoma-preventing agents.

Los Angeles, California - Stand Up To Cancer (SU2C), the charitable initiative aimed at bringing new treatments to cancer patients quickly, today announced Catalyst, a new program that will use funding and materials from the pharmaceutical, biotechnology, diagnostic and medical devices industries to accelerate research on cancer prevention, detection and treatment. Founding collaborator Merck; and Bristol-Myers Squibb Company, and Genentech, a member of the Roche Group, are Charter Supporters.

Baltimore, Maryland - Researchers led by teams at the Johns Hopkins Bloomberg School of Public Health and Wenzhou Medical University of China have discovered a way to keep adult stem cells that are destined to become testosterone-producing cells multiplying and on track to fulfill their fate, a new study reports.

Washington, DC - Researchers at the National Institutes of Health Clinical Center, in collaboration with extramural organizations, have sequenced nearly the entire genome of human, mouse and rat Pneumocystis. This organism causes a life-threatening pneumonia in immunosuppressed hosts. Pneumocystis was one of the first infections that led to the initial recognition of the HIV/AIDS epidemic. It has been responsible for thousands of deaths over the past 30 years and remains a significant risk in the HIV/AIDS population as well as in transplant recipients and other immunosuppressed patients.

Baltimore, Maryland - A simulation of how the so-called “superbug” carbapenem-resistant Enterobacteriaceae (CRE) might spread among health care facilities found that coordinated efforts prevented more than 75 percent of the often-severe infections that would have otherwise occurred over a five-year period.